We just received data on a new analyst forecast for $OCUL. Daniil Gataulin from Chardan Capital set a price target of 21.0 for OCUL.
To track analyst ratings and price targets for $OCUL, check out Quiver Quantitative's $OCUL forecast page.
Should you buy $OCUL?
Some analysts are better than others. To view the past performance of Chardan Capital, check out Quiver’s Analyst Ratings dashboard. You can also see Quiver’s Analyst Buys Strategy, which uses a proprietary method to track the companies being recommended by the top Wall Street analysts.
$OCUL Price Targets
Multiple analysts have issued price targets for $OCUL recently. We have seen 7 analysts offer price targets for $OCUL in the last 6 months, with a median target of $21.0.
Here are some recent targets:
- Daniil Gataulin from Chardan Capital set a target price of $21.0 on 02/18/2026
- Serge Belanger from Needham set a target price of $20.0 on 12/08/2025
- Yi Chen from HC Wainwright & Co. set a target price of $21.0 on 12/08/2025
- Tara Bancroft from TD Cowen set a target price of $20.0 on 10/30/2025
- Colleen Kusy from Baird set a target price of $24.0 on 10/03/2025
- Biren Amin from Piper Sandler set a target price of $31.0 on 10/03/2025
- Jonathan Wolleben from JMP Securities set a target price of $29.0 on 10/01/2025
$OCUL Insider Trading Activity
$OCUL insiders have traded $OCUL stock on the open market 15 times in the past 6 months. Of those trades, 0 have been purchases and 15 have been sales.
Here’s a breakdown of recent trading of $OCUL stock by insiders over the last 6 months:
- PRAVIN DUGEL (See Remarks) has made 0 purchases and 2 sales selling 146,376 shares for an estimated $1,387,721.
- NAMRATA SAROJ (Chief Business Officer) sold 25,865 shares for an estimated $277,790
- DONALD NOTMAN (Chief Operating Officer) has made 0 purchases and 4 sales selling 24,002 shares for an estimated $218,119.
- JEFFREY S. HEIER (Chief Scientific Officer) has made 0 purchases and 2 sales selling 13,565 shares for an estimated $152,820.
- PETER KAISER (Chief Development Officer) has made 0 purchases and 2 sales selling 12,664 shares for an estimated $142,725.
- TODD ANDERMAN (Chief Legal Officer) sold 11,132 shares for an estimated $137,368
- SANJAY NAYAK (Chief Strategy Officer) has made 0 purchases and 2 sales selling 12,233 shares for an estimated $116,241.
- NADIA WAHEED (Chief Medical Officer) sold 7,863 shares for an estimated $71,081
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$OCUL Hedge Fund Activity
We have seen 153 institutional investors add shares of $OCUL stock to their portfolio, and 96 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- VR ADVISER, LLC removed 5,845,915 shares (-44.4%) from their portfolio in Q4 2025, for an estimated $70,969,408
- BLACKROCK, INC. added 5,045,557 shares (+47.8%) to their portfolio in Q4 2025, for an estimated $61,253,061
- DEEP TRACK CAPITAL, LP removed 3,861,723 shares (-32.4%) from their portfolio in Q4 2025, for an estimated $46,881,317
- MILLENNIUM MANAGEMENT LLC added 3,736,560 shares (+3136.1%) to their portfolio in Q3 2025, for an estimated $43,680,386
- POINT72 ASSET MANAGEMENT, L.P. added 2,697,107 shares (+141.6%) to their portfolio in Q3 2025, for an estimated $31,529,180
- VANGUARD GROUP INC added 2,411,953 shares (+26.3%) to their portfolio in Q4 2025, for an estimated $29,281,109
- JANUS HENDERSON GROUP PLC added 2,180,702 shares (+106.5%) to their portfolio in Q4 2025, for an estimated $26,473,722
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
